Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
Pulmonx Corporation (LUNG) had Stock-Based Compensation of $7.83M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$22.76M |
|
$-10.08M |
|
$5.01M |
|
$17.74M |
|
$31.81M |
|
$-9.06M |
|
$-0.89M |
|
$-9.95M |
|
$-9.95M |
|
$-10.08M |
|
$-10.08M |
|
$-10.08M |
|
$-10.08M |
|
$-9.06M |
|
$-8.71M |
|
42.47M |
|
42.47M |
|
$-0.24 |
|
$-0.24 |
|
| Balance Sheet Financials | |
$88.13M |
|
$1.89M |
|
$26.60M |
|
$114.73M |
|
$20.41M |
|
$37.43M |
|
$55.13M |
|
$75.54M |
|
$39.20M |
|
$36.86M |
|
$39.20M |
|
42.95M |
|
| Cash Flow Statement Financials | |
$-15.31M |
|
$-0.01M |
|
$1.51M |
|
$70.01M |
|
$56.10M |
|
$-13.91M |
|
|
Stock-Based Compensation |
$7.83M |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.32 |
|
-- |
|
-- |
|
0.49 |
|
0.96 |
|
77.97% |
|
-39.80% |
|
-39.80% |
|
-- |
|
-43.71% |
|
-44.30% |
|
$-15.32M |
|
-- |
|
-- |
|
-- |
|
0.20 |
|
0.31 |
|
1.86 |
|
48.44 |
|
-25.72% |
|
-27.34% |
|
-8.79% |
|
-13.16% |
|
$0.91 |
|
$-0.36 |
|
$-0.36 |
|